Company Analysis Zydus Lifesciences Limited
1. Summary
Advantages
- The stock's return over the last year (38.1%) is higher than the sector average (10.49%).
- Current debt level 2.75% is below 100% and has decreased over 5 years from 33.64%.
- The company's current efficiency (ROE=20.67%) is higher than the sector average (ROE=10.72%)
Disadvantages
- Price (975.1 βΉ) is higher than fair price (559.83 βΉ)
- Dividends (0.7255%) are below the sector average (9.57%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Zydus Lifesciences Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | -2.1% | -1.5% | 1.7% |
| 90 days | -7.1% | -10.5% | -1.6% |
| 1 year | 38.1% | 10.5% | 8% |
ZYDUSLIFE vs Sector: Zydus Lifesciences Limited has outperformed the "Healthcare" sector by 27.61% over the past year.
ZYDUSLIFE vs Market: Zydus Lifesciences Limited has outperformed the market by 30.09% over the past year.
Stable price: ZYDUSLIFE is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ZYDUSLIFE with weekly volatility of 0.7327% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (975.1 βΉ) is higher than the fair price (559.83 βΉ).
Price is higher than fair: The current price (975.1 βΉ) is 42.6% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (13.76) is lower than that of the sector as a whole (59.63).
P/E vs Market: The company's P/E (13.76) is lower than that of the market as a whole (65.53).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.4) is lower than that of the sector as a whole (6.64).
P/BV vs Market: The company's P/BV (2.4) is lower than that of the market as a whole (6.53).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.72) is lower than that of the sector as a whole (9.32).
P/S vs Market: The company's P/S indicator (2.72) is lower than that of the market as a whole (18.85).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (9.52) is lower than that of the sector as a whole (141.59).
EV/Ebitda vs Market: The company's EV/Ebitda (9.52) is lower than that of the market as a whole (25.16).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 45.6% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (45.6%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-3.2%).
5.4. ROE
ROE vs Sector: The company's ROE (20.67%) is higher than that of the sector as a whole (10.72%).
ROE vs Market: The company's ROE (20.67%) is higher than that of the market as a whole (3.59%).
5.5. ROA
ROA vs Sector: The company's ROA (14.03%) is higher than that of the sector as a whole (7.64%).
ROA vs Market: The company's ROA (14.03%) is higher than that of the market as a whole (7.91%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (13.82%) is lower than that of the sector as a whole (15.91%).
ROIC vs Market: The company's ROIC (13.82%) is lower than that of the market as a whole (15.54%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.7255% is below the average for the sector '9.57%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.7255% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 0.7255% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (16.09%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
